Skip to main content
. 2018 Jan 19;10:143–152. doi: 10.2147/CLEP.S145636

Table 3.

Risk of CRC according to GRS and FH of CRC

Risk factor Characteristics Cases, n (%) Controls, n (%) OR (95% CI)
Model 1a Model 2b Model 3c
GRSd Very low 134 (5.7) 220 (10.0) Ref. Ref. Ref.
Low 175 (7.4) 220 (10.0) 1.31 (0.98–1.75) 1.36 (0.99–1.87) 1.35 (0.98–1.86)
Low–medium 383 (16.2) 439 (20.0) 1.44 (1.11–1.85) 1.47 (1.12–1.94) 1.48 (1.12–1.95)
Medium 431 (18.2) 439 (20.0) 1.61 (1.25–2.08) 1.53 (1.17–2.02) 1.51 (1.14–1.98)
Medium–high 548 (23.2) 441 (20.0) 2.04 (1.59–2.61) 2.09 (1.59–2.73) 2.08 (1.58–2.72)
High 300 (12.7) 220 (10.0) 2.24 (1.70–2.95) 2.33 (1.72–3.14) 2.32 (1.71–3.13)
Very high 392 (16.6) 219 (10.0) 2.94 (2.24–3.86) 3.00 (2.24–4.02) 2.96 (2.20–3.97)
FH of CRC No FH 1833 (77.6) 1825 (83.0) Ref. Ref. Ref.
SDR only 214 (9.1) 159 (7.2) 1.32 (1.07–1.64) 1.53 (1.21–1.95) 1.53 (1.21–1.95)
FDR 316 (13.4) 214 (9.7) 1.47 (1.22–1.77) 1.86 (1.52–2.29) 1.83 (1.49–2.25)

Notes: Values are expressed as n (%).

a

Adjusted for sex and age.

b

Adjusted for sex, age (continuous), education (≤9, 10–11, ≥12 years), previous colonoscopy (yes/no), smoking (current/former/never), HRT among women (yes/no), BMI before diagnosis (weight in kilograms divided by squared height in meters); missing values, n = 75.

c

Adjustment like in model 2, plus additional adjustment for FH in analyses for GRS, and additional adjustment for GRS in analyses for FH, respectively; missing values, n = 75.

d

GRS with risk alleles as defined in discovery study (Table S1); classification: very low, ≤10th percentile; low, 10th–20th percentile; low–medium, 20th–40th percentile; medium, 40th–60th percentile; medium–high, 60th–80th percentile; high, 80th–90th percentile; very high, >90th percentile.

Abbreviations: BMI, body mass index; CRC, colorectal cancer; FDR, first-degree relative; FH, family history; GRS, genetic risk score; HRT, hormone replacement therapy; OR, odds ratio; Ref., reference; SDR, second-degree relative.